You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

METOPIRONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Metopirone patents expire, and what generic alternatives are available?

Metopirone is a drug marketed by Hra Pharma and is included in one NDA.

The generic ingredient in METOPIRONE is metyrapone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the metyrapone profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for METOPIRONE?
  • What are the global sales for METOPIRONE?
  • What is Average Wholesale Price for METOPIRONE?
Drug patent expirations by year for METOPIRONE
Drug Prices for METOPIRONE

See drug prices for METOPIRONE

Recent Clinical Trials for METOPIRONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Foundation for a Smoke-Free WorldPhase 1/Phase 2
Embera NeuroTherapeutics, Inc.Phase 1/Phase 2
Rose Research Center, LLCPhase 1/Phase 2

See all METOPIRONE clinical trials

Pharmacology for METOPIRONE

US Patents and Regulatory Information for METOPIRONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hra Pharma METOPIRONE metyrapone CAPSULE;ORAL 012911-002 Aug 9, 1996 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hra Pharma METOPIRONE metyrapone TABLET;ORAL 012911-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.